Dose daily

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference that will be held on 8–9 October 2026 in Kolkata. The...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...

CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017

The Central Drugs Standard Control Organisation (CDSCO), functioning under the Directorate General of Health Services, Ministry of Health...

New COVID-19 Cases Detected in Andhra Pradesh; Health Teams on Alert

State health departments have initiated targeted surveillance protocols following the detection of eight active Covid-19 positive cases and two related deaths in Andhra Pradesh...

India Launches e-Sushrut Clinic to Digitally Empower Small Clinics Across the Nation

The National Health Authority, working alongside the Centre for Development of Advanced Computing, has rolled out e-Sushrut Clinic, a no-cost, web-based platform built under the Ayushman Bharat...

Manipal Hospitals Enters Western India with ₹6,300 Crore Sahyadri Hospitals Acquisition

In a major consolidation within India’s healthcare sector, Manipal Hospitals (MHEL) have announced the strategic acquisition of Sahyadri Hospitals in a landmark deal valued at ₹6,300...

Dr. Reddy’s Announces First-to-Market Launch of Generic Bosulif®️ Tablets in the U.S.

Dr. Reddy’s Laboratories Ltd. has launched Bosutinib Tablets 400mg, a first-to-market generic equivalent of Wyeth LLC’s Bosulif®, in the United States. As a first-to-file product,...

Novo Nordisk’s Denecimig shows positive phase 3 results at ISTH 2026

Novo Nordisk  announced encouraging interim results from its phase 3 FRONTIER 4 long-term extension study at the International Society on Thrombosis and Haemostasis (ISTH)...

India Takes Step Towards Stronger Health Research, Invites Public Opinion on Draft Policy

The Department of Health Research, under the Ministry of Health and Family Welfare, has released the draft National Health Research Policy 2026, setting out...